Clinical Trials

ATLAS: A Phase 2, Open-label Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinoma


Study ID
Clovis Oncology CO-338-085 ATLAS

NCT Number
NCT03397394 (Click on the NCT number for more information about the trial)

Research Study Number
2018-0433

Principle Investigator
Dr. Robert Alter

Phase
II

Sponsor
Clovis Oncology, Inc.


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now